Amas, Ritchel T.

HRN: 19-07-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2025
CEFUROXIME 1.5GM (VIAL)
11/07/2025
11/14/2025
IVT
1.5gms
On Call To OR Then Q 8
Pelvic Laparotomy
Checking Initial Appropriateness 
11/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/07/2025
11/14/2025
IVT
500 Mg
Q8
Pelvic Laparotomy
Checking Initial Appropriateness 
11/08/2025
DOXYCYCLINE 100MG (CAP)
11/08/2025
11/22/2025
PO
100mg
Q12
S/P Laparotomy And Left Salpingectomy
Waiting Final Action 
11/08/2025
CEFUROXIME 500MG (TAB)
11/08/2025
11/16/2025
PO
500mg
Bid
S/P Laparotomy And Left Salpingectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: